Advanced laser imaging illuminates molecular interactions driving lung cancer growth

FHS
March 19, 2024
11:24 am

Researchers have shown for the first time that a crucial interface in a protein that drives cancer growth could act as a target for more effective treatments.

Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch 30-Aug-2023 / 22:20 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

August 31, 2023

FDA to hold off on enforcing some parts of major supply chain law until 2024

The FDA on Friday published final guidance explaining how it will not enforce some provisions of a major supply chain law until next year, rather

August 29, 2023

Migraine linked to increased risk of inflammatory bowel disease in new study

A nationwide cohort study reveals that individuals with migraine have a 1.3-fold higher risk of developing inflammatory bowel disease (IBD), suggesting a significant connection between

January 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.